James Miser - 01 Aug 2020 Form 3 Insider Report for LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)

Role: Chief Medical Officer
Signature: /s/ James Miser
Issuer symbol: LIXT
Transactions as of: 01 Aug 2020
Net transactions value: $0
Form type: 3
Filing time: 21 Nov 2022, 18:15:32 UTC
Next filing: 21 Nov 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	LIXT	Options to Purchase Common Stock							01 Aug 2020	Common Stock	83,334	$7.14	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

On August 1, 2020, the Reporting Person was granted five-year options to purchase an aggregate of 83,334 (post-split) shares of the Company's Common Stock vesting 20,833 shares on the date of grant and 25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 25% on the third anniversary of the grant date until fully vested.